Device type · OOG
Knee Arthroplasty Implantation System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OOG
Orthopedic
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
33
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Knee Arthroplasty Implantation System
- Product code
- OOG
- Device class
- Class II
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3560
- Specialty
- Orthopedic Surgery, Joint Reconstruction
- FDA record
- Classification database entry for OOG
Latest FDA decisions
K230850 · Decided Dec 20, 2023 · 267 days after receipt
Device type: Knee Arthroplasty Implantation System (OOG) · Orthopedic Surgery
- Triathlon AS-1510(k)
K203421 · Decided Apr 19, 2021 · 150 days after receipt
Device type: Knee Arthroplasty Implantation System (OOG) · Orthopedic Surgery
Reports received
33
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
4
12% of reports
Injury reports
29
88% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 2 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 2 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 2 | 0 | 0 | 0 |
| May 24 | 2 | 7 | 0 | 0 |
| Jun 24 | 0 | 9 | 0 | 0 |
| Jul 24 | 1 | 23 | 0 | 0 |
| Aug 24 | 0 | 15 | 0 | 0 |
| Sep 24 | 1 | 4 | 0 | 0 |
| Oct 24 | 0 | 4 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 2 | 1 | 0 | 0 |
| Apr 25 | 0 | 1 | 0 | 0 |
| May 25 | 1 | 1 | 0 | 0 |
| Jun 25 | 0 | 7 | 0 | 0 |
| Jul 25 | 0 | 5 | 0 | 0 |
| Aug 25 | 1 | 3 | 0 | 0 |
| Sep 25 | 0 | 4 | 0 | 0 |
| Oct 25 | 0 | 1 | 0 | 0 |
| Nov 25 | 0 | 5 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 2 | 1 | 0 | 0 |
| Mar 26 | 0 | 7 | 0 | 0 |
| Apr 26 | 0 | 1 | 0 | 0 |
| May 26 | 0 | 2 | 0 | 0 |
| Jun 26 | 0 | 4 | 0 | 0 |
| Jul 26 | 1 | 2 | 0 | 0 |
| Aug 26 | 1 | 2 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 0 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Aesculap27
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Patient-Device Incompatibility28
- Adverse Event Without Identified Device or Use Problem1
- Application Program Problem: Parameter Calculation Error1
- Fracture1
- Loosening of Implant Not Related to Bone-Ingrowth1
- Patient Device Interaction Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Failure of Implant19
- Insufficient Information6
- No Clinical Signs, Symptoms or Conditions4
- Joint Laxity2
- Aseptic loosening1
- Inflammation1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0138-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
Z-0139-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
Z-0140-2016 · Started Aug 31, 2015 · Posted by FDA Oct 21, 2015
Reason given: May contain small amounts of ethylene glycol residue
Cause as FDA categorized it: Process design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.